High Expression of RECQL Protein in ER-Positive Breast Tumours Is Associated With a Better Survival
Ardalan Mahmoodi(University of Toronto), Mohammad R. Akbari(University of Toronto), Amir Samani(University of Toronto), Vasily Giannakeas(Women's College Hospital), Sharon Nofech‐Mozes(Sunnybrook Health Science Centre), Sudha Sharma(Shobhit University), Ahmed Shoqafi(University of Nottingham), Jean‐Yves Masson(Université Laval), Cezary Cybulski(International Hereditary Cancer Center), Steven A. Narod(Women's College Hospital), Ping Sun(University of Toronto), Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust)
Cited by 2
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
|PLoS ONE|2015|906
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ
|JAMA Oncology|2015|618